Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 849

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

RNA virus error catastrophe: Direct molecular test by using ribavirin

Open access
Crotty, Shane, Cameron, Craig E., Andino, Raul·2001·Proceedings of the National Academy of Sciences

Abstract

RNA viruses evolve rapidly. One source of this ability to rapidly change is the apparently high mutation frequency in RNA virus populations. A high mutation frequency is a central tenet of the quasispecies theory. A corollary of the quasispecies theory postulates that, given their high mutation frequency, animal RNA viruses may be susceptible to error catastrophe, where they undergo a sharp drop in viability after a modest increase in mutation frequency. We recently showed that the important broad-spectrum antiviral drug ribavirin (currently used to treat hepatitis C virus infections, among others) is an RNA virus mutagen, and we proposed that ribavirin's antiviral effect is by forcing RNA viruses into error catastrophe. However, a direct demonstration of error catastrophe has not been made for ribavirin or any RNA virus mutagen. Here we describe a direct demonstration of error catastrophe by using ribavirin as the mutagen and poliovirus as a model RNA virus. We demonstrate that ribavirin's antiviral activity is exerted directly through lethal mutagenesis of the viral genetic material. A 99.3% loss in viral genome infectivity is observed after a single round of virus infection in ribavirin concentrations sufficient to cause a 9.7-fold increase in mutagenesis. Compiling data on both the mutation levels and the specific infectivities of poliovirus genomes produced in the presence of ribavirin, we have constructed a graph of error catastrophe showing that normal poliovirus indeed exists at the edge of viability. These data suggest that RNA virus mutagens may represent a promising new class of antiviral drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.111085598

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 47

  1. 10.1128/jvi.64.2.664-671.1990 · DOI
  2. E Domingo, J J Holland, P Ahlquist RNA Genetics (CRC, Boca Raton, FL, 1988).
  3. E Domingo, J J Holland The Evolutionary Biology of Viruses, ed S S Morse (Raven, New York), pp. 161–184 (1994).
  4. 10.1006/viro.2000.0320 · DOI · Paper page
  5. 10.1016/0092-8674(78)90223-4 · DOI · Paper page
  6. 10.1126/science.148.3666.97 · DOI
  7. M Eigen, C Biebricher RNA Genetics, eds E Domingo, J J Holland, P Ahlquist (CRC, Boca Raton, FL), pp. 211–245 (1988).
  8. 10.1126/science.7041255 · DOI · Paper page
  9. J J Holland, J C De La Torre, D A Steinhauer Curr Top Microbiol Immunol 176, 1–20 (1992).
  10. E Domingo, J J Holland, C Biebricher, M Eigen Molecular Basis of Virus Evolution, eds A J Gibbs, C H Calisher, F Garcia-Arenal (Cambridge Univ. Press, Cambridge, U.K.), pp. 181–191 (1995). · DOI
  11. 10.1128/jvi.64.8.3960-3962.1990 · DOI · Paper page
  12. 10.1128/jvi.71.5.3636-3640.1997 · DOI
  13. 10.1038/82191 · DOI · Paper page
  14. 10.1073/pnas.96.4.1492 · DOI · Paper page
  15. 10.1128/JVI.74.18.8316-8323.2000 · DOI · Paper page
  16. 10.1056/NEJM199811193392102 · DOI · Paper page
  17. 10.1056/NEJM199811193392101 · DOI · Paper page
  18. 10.1016/S0166-3542(98)00029-1 · DOI
  19. 10.1056/NEJM198601023140104 · DOI · Paper page
  20. 10.1128/JVI.73.11.9485-9495.1999 · DOI
  21. 10.1074/jbc.M002671200 · DOI
  22. 10.1128/JVI.74.14.6394-6400.2000 · DOI
  23. 10.1128/jvi.59.2.377-383.1986 · DOI · Paper page
  24. 10.1016/0092-8674(87)90492-2 · DOI
  25. 10.1128/jvi.57.1.81-90.1986 · DOI
  26. 10.1016/0042-6822(80)90114-2 · DOI
  27. 10.1128/jvi.57.3.715-720.1986 · DOI
  28. 10.1128/jvi.63.5.2063-2071.1989 · DOI
  29. 10.1128/jvi.63.12.5030-5036.1989 · DOI
  30. 10.1073/pnas.89.7.2531 · DOI
  31. 10.1038/301674a0 · DOI · Paper page
  32. 10.1128/jvi.57.1.246-257.1986 · DOI · Paper page
  33. 10.1128/AAC.30.2.201 · doi:10.1128/aac.30.2.201
  34. R A Smith, W Kirkpatrick Ribavirin, A Broad Spectrum Antiviral Agent (Academic, New York, 1980).
  35. R A Smith, V Knight, J A D Smith Clinical Applications of Ribavirin (Academic, Orlando, FL, 1984).
  36. 10.1126/science.177.4050.705 · DOI · Paper page
  37. 10.1016/0378-1119(93)90047-7 · DOI · Paper page
  38. 10.1073/pnas.86.14.5345 · DOI · Paper page
  39. 10.1111/j.1749-6632.1977.tb21953.x · doi:10.1111/j.1749-6632.1977.tb21953.x
  40. 10.1016/0042-6822(89)90413-3 · doi:10.1016/0042-6822(89)90413-3
  41. 10.1016/0166-3542(85)90013-0 · doi:10.1016/0166-3542(85)90013-0
  42. 10.1146/annurev.pa.20.040180.001355 · doi:10.1146/annurev.pa.20.040180.001355
  43. 10.1073/pnas.70.4.1174 · DOI · Paper page
  44. 10.1016/0166-3542(85)90012-9 · doi:10.1016/0166-3542(85)90012-9
  45. 10.1128/jvi.5.5.559-567.1970 · DOI · Paper page
  46. 10.1016/0042-6822(66)90096-1 · doi:10.1016/0042-6822(66)90096-1
  47. 10.1099/0022-1317-69-2-265 · doi:10.1099/0022-1317-69-2-265

Cited by

See all 849

Metadata

Authors
Crotty, S., Cameron, C. E., & Andino, R.
Venue
Proceedings of the National Academy of Sciences
Published
2001-05-22
Volume
98
Issue
12
Pages
6895-6900
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2153918414
Cited by
849
References
3
FWCI
21.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RNA virus error catastrophe: Direct molecular test by using ribavirin. https://app.cochat.ai/papers/10.1073/pnas.111085598
The paper
Crotty, S., Cameron, C. E., & Andino, R. (2001). RNA virus error catastrophe: Direct molecular test by using ribavirin. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.111085598

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.